SCHOENTJES, BRUNO,PONCELET, ALAIN PHILIPPE,DOYON, JULIEN GEORGES PIERRE-OLIVIER,LINDERS, JOANNES THEODORUS MARIA,MEERPOEL, LIEVEN,VER DONCK, LUC AUGUST LAURENTIUS
申请号：
CA2722122
公开号：
CA2722122C
申请日:
2009.04.27
申请国别(地区):
CA
年份:
2017
代理人:
摘要：
The present invention relates to a compound of formula (I), including any stereochemically isomeric form thereof, wherein the substituents are as defined in the specification and the claims； a N-oxide thereof, a pharmaceutically acceptable salt thereof or a solvate thereof； provided that the compound is other than formula (B) or a pharmaceutically acceptable salt thereof. The claimed compounds are useful for the treatment of a disease, the treatment of which is affected, mediated or facilitated by activating the GHS1A-r receptor. The invention also relates to pharmaceutical compositions thereof and processes for the preparation thereof.
